Increased disease activity, severity and autoantibody positivity in rheumatoid arthritis patients with co-existent bronchiectasis

International Journal of Rheumatic Diseases

Volumn 20, Issue 12, 2017, Pages 2003-2011

  Perry, Elizabeth ^a,b   Eggleton, Paul ^b   De Soyza, Anthony ^c,d   Hutchinson, David ^e   Kelly, Clive ^f  

^a MUSGROVE PARK HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d FREEMAN HOSPITAL   (United Kingdom)

^e ROYAL CORNWALL HOSPITALS NHS TRUST   (United Kingdom)

^f QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

anti CCP; bronchiectasis; disease activity; rheumatoid arthritis; rheumatoid factor

Indexed keywords

AUTOANTIBODY; C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; IMMUNOGLOBULIN M; RHEUMATOID FACTOR; BIOLOGICAL MARKER;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOLOGICAL THERAPY; BRONCHIECTASIS; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DAS28; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RADIOLOGY; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY TRACT INFECTION; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEROLOGY; AGED; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; COMPLICATION; DIAGNOSTIC IMAGING; ENGLAND; IMMUNOLOGY; MIDDLE AGED; MULTICENTER STUDY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SMOKING; VERY ELDERLY; X-RAY COMPUTED TOMOGRAPHY;

AGED; AGED, 80 AND OVER; ANTI-CITRULLINATED PROTEIN ANTIBODIES; ARTHRITIS, RHEUMATOID; BIOMARKERS; BRONCHIECTASIS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ENGLAND; FEMALE; HUMANS; MALE; MIDDLE AGED; RHEUMATOID FACTOR; RISK FACTORS; SEROLOGIC TESTS; SEVERITY OF ILLNESS INDEX; SMOKING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84937509880     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/1756-185X.12702     Document Type: Article

References (32)

1. Walker WC (1967) Pulmonary infections and rheumatoid arthritis. Q J Med 36 (142), 239–51.
2. Allain J, Saraux A, Guedes C, Valls I, Devauchelle V, Le Goff P (1997) Prevalence of symptomatic bronchiectasis in patients with rheumatoid arthritis. Rev Rhum 64 (10), 531–7.
3. Cortet B, Perez T, Roux N et al. (1997) Pulmonary function tests and high resolution computed tomography of the lungs in patients with rheumatoid arthritis. Ann Rheum Dis 56 (10), 596–600.
4. Hassan WU, Keaney NP, Holland CD, Kelly CA (1995) High resolution computed tomography of the lung in lifelong non-smoking patients with rheumatoid arthritis. Ann Rheum Dis 54, 308–10.
5. Mohd Noor N, Mohd Shahrir MS, Shahid MS, Abdul Manap R, Shahizon Azura AM, Azhar Shah S (2009) Clinical and high resolution computed tomography characteristics of patients with rheumatoid arthritis lung disease. Int J Rheum Dis 12, 136–44.
6. Remy-Jardin M, Remy J, Cortet B, Mauri F, Delcambre B (1994) Lung changes in rheumatoid arthritis: CT findings. Radiology 193 (2), 375–82.
7. Despaux J, Manzoni P, Toussirot E, Auge B, Cedoz JP, Wendling D (1998) Prospective study of the prevalence of bronchiectasis in rheumatoid arthritis using high-resolution computed tomography. Rev Rhum 65 (7–9), 453–61.
8. McMahon MJ, Swinson DR, Shettar S et al. (1993) Bronchiectasis and rheumatoid arthritis: a clinical study. Ann Rheum Dis 52 (11), 776–9.
9. Lieberman-Maran L, Orzano IM, Passero MA, Lally EV (2006) Bronchiectasis in rheumatoid arthritis: report of four cases and a review of the literature–implications for management with biologic response modifiers. Semin Arthritis Rheum 35 (6), 379–87.
10. Geri G, Dadoun S, Bui T et al. (2011) Risk of infections in bronchiectasis during disease-modifying treatment and biologics for rheumatic diseases. BMC Infect Dis 11, 304.
11. Goeminne PC, Verschueren P, Scheers H, Dupont LJ (2012) Safety of immunomodulatory therapy in patients with bronchiectasis associated with rheumatic disease and IBD: a retrospective and cohort analysis. Clin Rheumatol 31 (2), 367–73.
12. Swinson DR, Symmons D, Suresh U, Jones M, Booth J (1997) Decreased survival in patients with co-existent rheumatoid arthritis and bronchiectasis. Br J Rheumatol 36 (6), 689–91.
13. Despaux J, Polio JC, Toussirot E, Dalphin JC, Wendling D (1996) Rheumatoid arthritis and bronchiectasis. A retrospective study of fourteen cases. Rev Rhum 63 (11), 801–8.
14. Despaux J, Toussirot E, Wendling D (1997) Bronchiectasis and rheumatoid arthritis. Incidence and etiopathogenic aspects. Review of the literature. Rev Med Interne 18, 144–52.
15. Shadick NA, Fanta CH, Weinblatt ME, O'Donnell W, Coblyn JS (1994) Bronchiectasis. A late feature of severe rheumatoid arthritis. Medicine 73 (3), 161–70.
16. Demoruelle MK, Weisman MH, Simonian PL et al. (2012) Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity? Arthritis Rheum 64 (6), 1756–61.
17. Wilsher M, Voight L, Milne D et al. (2012) Prevalence of airway and parenchymal abnormalities in newly diagnosed rheumatoid arthritis. Respir Med 106 (10), 1441–6.
18. Cole PJ (1986) Inflammation: a two-edged sword–the model of bronchiectasis. Eur J Respir Dis Suppl 147, 6–15.
19. Kochbati S, Boussema F, Ben Miled M et al. (2003) Bronchiectasis in rheumatoid arthritis. High resolution computed pulmonary tomography. Tunis Med 81 (10), 768–73.
20. Inui N, Enomoto N, Suda T, Kageyama Y, Watanabe H, Chida K (2008) Anti-cyclic citrullinated peptide antibodies in lung diseases associated with rheumatoid arthritis. Clin Biochem 41 (13), 1074–7.
21. Aubart F, Crestani B, Nicaise-Roland P et al. (2011) High levels of anti-cyclic citrullinated peptide autoantibodies are associated with co-occurrence of pulmonary diseases with rheumatoid arthritis. J Rheumatol 38 (6), 979–82.
22. Mori S, Koga Y, Sugimoto M (2012) Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis. Respir Med 106 (11), 1591–9.
23. Kaushik VV, Hutchinson D, Desmond J, Lynch MP, Dawson JK (2004) Association between bronchiectasis and smoking in patients with rheumatoid arthritis. Ann Rheum Dis 63 (8), 1001–2.
24. Aletaha D, Neogi T, Silman AJ et al. (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62 (9), 2569–81.
25. Fransen J, Creemers MC, Van Riel PL (2004) Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology 43 (10), 1252–5.
26. Taylor HG, Fowler PD, David MJ, Dawes PT (1991) Intra-articular steroids: confounder of clinical trials. Clin Rheumatol 10 (1), 38–42.
27. Cutolo M, Seriolo B, Pizzorni C et al. (2008) Use of glucocorticoids and risk of infections. Autoimmun Rev 8, 153–5.
28. Dixon WG, Abrahamowicz M, Beauchamp ME et al. (2012) Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis. Ann Rheum Dis 71 (7), 1128–33.
29. Kallberg H, Ding B, Padyukov L et al. (2011) Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis 70 (3), 508–11.
30. Reynisdottir G, Karimi R, Joshua V et al. (2014) Structural changes and antibody enrichment in the lungs are early features of anti-citrullinated protein antibody-positive rheumatoid arthritis. Arthritis Rheum 66 (1), 31–9.
31. Perry E, Kelly C, Eggleton P, De Soyza A, Hutchinson D (2014) The lung in ACPA-positive rheumatoid arthritis: an initiating site of injury? Rheumatology 53 (11), 1940–50.
32. Perry E, Stenton C, Kelly C, Eggleton P, Hutchinson D, De Soyza A (2014) RA autoantibodies as predictors of rheumatoid arthritis in non-cystic fibrosis bronchiectasis patients. Eur Respir J 44 (4), 1082–5.